R3THA Rehabilitation Feasibility and Usability Study
Launched by KESSLER FOUNDATION · Feb 28, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The R3THA Rehabilitation Feasibility and Usability Study is a clinical trial designed to explore how a special device called R3THA can help people recovering from a stroke regain the use of their hands and arms. The study aims to see if this device can be effectively used at home through online sessions with trained therapists. If you are between the ages of 20 and 80 and can move your arms and hands enough to play video games, you may be able to participate. Additionally, you’ll need to have internet access at home and be comfortable using a computer.
Participants in this study will use the R3THA device during remote sessions, which means you will be guided by a clinician through your rehabilitation from the comfort of your own home. This trial is currently looking for participants, but certain conditions will disqualify individuals, such as severe muscle stiffness or significant thinking difficulties. If you or a family member is interested in finding out more about this study and whether you might qualify, it could be a great opportunity to engage in rehabilitation that fits your schedule and needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. must be between the ages of 20 and 80
- • 2. must have enough movement in my arms and hands to actively interact with the video games as determined by study staff
- • 3. must have internet access at home.
- • 4. must be comfortable performing basic functions on a computer, such as browsing the internet.
- • 5. must be able to sit without a loss of balance while performing activities with my arms and hands as determined by study staff.
- Exclusion Criteria:
- • Severe muscle spasms or stiffness (spasticity) in the affected upper limb that limits movement, as determined by study staff.
- • 2) Thinking problems or have difficulty following instructions 3) Unable to interact with an entire computer screen due to spatial neglect 4) Difficulty understanding words spoken to me (Receptive aphasia) 5) Any other disabling nervous system condition (besides stroke) that has caused residual weakness, impaired range of motion, or spasticity 6) Severe arthritis that limits hand and arm movements 7) Not independent in functional activities/mobility prior to stroke
About Kessler Foundation
Kessler Foundation is a leading nonprofit organization dedicated to advanced rehabilitation research and the development of innovative strategies to improve the lives of individuals with disabilities. With a strong emphasis on clinical trials and evidence-based practices, the Foundation collaborates with academic institutions, healthcare providers, and industry partners to explore novel therapeutic approaches and technologies. Its commitment to enhancing mobility, cognitive function, and overall quality of life for people with neurological and musculoskeletal conditions drives its mission to transform rehabilitation outcomes through cutting-edge research and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
West Orange, New Jersey, United States
Patients applied
Trial Officials
Kiran Karunakaran, PhD
Principal Investigator
Kessler Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported